Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Cincera Therapeutics
Cincera Therapeutics is a biotechnology company developing drugs to treat metabolic diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Phanes Therapeutics
Phanes Therapeutics is a biotech company that develops therapeutics for solid tumors and eye diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
NovelMed Therapeutics
NovelMed Therapeutics develops transformative treatments for orphan and non-orphan diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Abbisko Therapeutics
Abbisko Therapeutics develops small molecule drugs for cancer and other diseases.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 02.08.2017. Their latest investor BioGenerator. Their latest round Venture - Series Unknown
Cultivation Capital
Cultivation Capital is a venture capital firm that invests in early-stage technology startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
BioGenerator
BioGenerator provides seed investment to startup bioscience companies.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
BioGenerator
BioGenerator provides seed investment to startup bioscience companies.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Cultivation Capital
Cultivation Capital is a venture capital firm that invests in early-stage technology startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Argonautic Ventures
Argonautic Ventures is a venture capital firm that invests in emerging and mature industries to help transform their markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Robert Karr
Robert Karr has broad experience in the drug discovery and development process, including discovery/preclinical research, IND preparation, interactions with the FDA, the design and conduct of clinical trials, and investor relations. He currently serves as CSO of Tioma Therapeutics and previously served as President & CEO of Indalo (then called Antegrin Therapeutics) from 2012-2015. Prior roles have included President of Idera Pharmaceuticals, Senior Vice President of Strategic Management at Pfizer, and Vice President of Research and Development Strategy at Warner-Lambert. Dr. Karr received his B.S. (Honors) from Southwestern University in 1971 and his M.D (with highest honors) from the University of Texas Medical Branch in 1975.
current job
count Of Investments
Robert Karr
David Griggs
Dr. Griggs is a scientific expert in the field of integrin biology with over 20 years of experience managing drug research programs at large pharmaceutical companies (Searle, Pharmacia, and Pfizer) and in a university-based translational pharmacology center (the Center for World Health & Medicine at Saint Louis University). He has led teams that designed and implemented nearly two dozen in vitro integrin functional assays as well as diverse in vivo studies to evaluate efficacy, pharmacology, and safety of RGD peptidomimetic integrin antagonists. Dr. Griggs has authored more than 20 peer-reviewed scientific publications and holds several issued and pending U.S. patents. He received a B.S. degree in Biological Sciences from Northern Kentucky University and M.S. and Ph.D. degrees in Microbiology from the University of Illinois at Urbana-Champaign, and he completed postdoctoral studies in the Department of Genetics at Washington University in St. Louis.
current job
organization founded
David Griggs
Peter Ruminski
Peter Ruminski is a Instructor in Medicine, Division of Oncology at Washington University School of Medicine. He Attended Saint Louis University.
current job
organization founded
Peter Ruminski
Employee Profiles8
Robert Karr
Founder, Chief Executive Officer & President
Ramachandran Radhakrishnan
Sr. VP of Pharmaceutical Development